The exact mechanisms underlying tirzepatide-induced weight loss remain to be clarified
Additionally, it may help improve cholesterol levels and offer some heart health benefits
Managing stress , since chronic stress can lower glutathione levels over time
Pancreatitis and gallbladder disease, though uncommon, are recognised risks associated with GLP-1 receptor agonist use, as documented in the Summary of Product Characteristics (SmPC) for licensed agents in this class (such as semaglutide)
semaglutide and other GLP-1 receptor agonists [3,4,5,6,7,8,9,10]
Health Canada's Supplemented Foods Regulations entered a transition phase through December 2025, requiring premarket assessment for novel ingredients